Primary adenocarcinoma of the lung - histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma

被引:13
|
作者
Oskarsdottir, Gudrun Nina [1 ,2 ]
Bjornsson, Johannes [3 ]
Jonsson, Steinn [1 ,2 ]
Isaksson, Helgi J. [4 ]
Gudbjartsson, Tomas [2 ,5 ]
机构
[1] Landspitali Univ Hosp, Dept Pulmonol, Reykjavik, Iceland
[2] Univ Iceland, Fac Med, Reykjavik, Iceland
[3] Akureyri Hosp, Dept Pathol, Reykjavik, Iceland
[4] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
[5] Landspitali Univ Hosp, Dept Cardiothorac Surg, Reykjavik, Iceland
关键词
Lung adenocarcinoma; histology; classification; adenocarcinoma subtypes; INTERNATIONAL-ASSOCIATION; GRADING SYSTEM; PROGNOSTIC-SIGNIFICANCE; CANCER; SURVIVAL; MUTATIONS; RECURRENCE; THERAPY; PATTERN; MARKER;
D O I
10.1111/apm.12522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenocarcinoma is the most common histological type of lung carcinoma. Recently the histologic classification of adenocarcinomas in the lung was modified to better reflect biologic properties and prognosis. We reviewed the histology of all primary lung adenocarcinomas operated on in Iceland during a 20-year period and assessed the impact of histology on survival. This nationwide study included 285 patients (mean age 67 years, 57% female), who underwent resection in Iceland from 1991 to 2010. Tumors were reclassified according to the current IASLC/ATS/ERS classification system. Overall survival was estimated by the Kaplan-Meier method and Cox regression analysis used to evaluate prognostic factors of overall mortality. Acinar predominant adenocarcinoma was the most common histological subtype (46%) followed by solid-predominant (SPA) with mucin production comprised (23%). Non-invasive carcinomas were rare. A difference in survival between the histological adenocarcinoma subtypes was not seen (p = 0.32) and multivariate analysis showed that advanced stage and age predicted worse outcome, but histologic subtyping of adenocarcinoma did not. In this nation-wide study there was not a statistical difference in survival according to adenocarcinoma subtypes and the histological subtype did not predict mortality. Preinvasive and minimally invasive adenocarcinomas were rare.
引用
收藏
页码:384 / 392
页数:9
相关论文
共 50 条
  • [31] Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
    Dong, Yu-Jie
    Cai, Yi-Ran
    Zhou, Li-Juan
    Su, Dan
    Mu, Jing
    Chen, Xue-Jing
    Zhang, Li
    ONCOLOGY LETTERS, 2016, 11 (04) : 2552 - 2558
  • [32] Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma
    Gu, Jie
    Lu, Chunlai
    Guo, Jing
    Chen, Lingli
    Chu, Yiwei
    Ji, Yuan
    Ge, Di
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (05) : 474 - 480
  • [33] Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma
    Zhang, Dachuan
    Gao, Xie
    Yan, Zhantao
    He, Wenting
    Li, Qing
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (01) : 105 - 111
  • [34] FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma
    Kadota, Kyuichi
    Colovos, Christos
    Suzuki, Kei
    Rizk, Nabil P.
    Dunphy, Mark P. S.
    Zabor, Emily C.
    Sima, Camelia S.
    Yoshizawa, Akihiko
    Travis, William D.
    Rusch, Valerie W.
    Adusumilli, Prasad S.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) : 3598 - 3605
  • [35] Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma
    Kadota, Kyuichi
    Nitadori, Jun-ichi
    Sarkaria, Inderpal S.
    Sima, Camelia S.
    Jia, Xiaoyu
    Yoshizawa, Akihiko
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CANCER, 2013, 119 (05) : 931 - 938
  • [36] Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
    Boukansa, Sara
    Benbrahim, Zineb
    Gamrani, Sanaa
    Bardai, Sanae
    Bouguenouch, Laila
    Mazti, Asmae
    Boutahiri, Nadia
    Serraj, Mounia
    Amara, Bouchra
    Ouadnouni, Yassine
    Smahi, Mohamed
    Alami, Badreeddine
    Mellas, Nawfel
    El Fatemi, Hinde
    CANCER CONTROL, 2022, 29
  • [37] Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
    Zhao, Shilei
    Guo, Tao
    Li, Jinxiu
    Uramoto, Hidetaka
    Guan, Hongwei
    Deng, Wuguo
    Gu, Chundong
    ONCOTARGETS AND THERAPY, 2015, 8 : 3143 - 3152
  • [38] New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma
    Yanagawa, Naoki
    Shiono, Satoshi
    Abiko, Masami
    Ogata, Shin-ya
    Sato, Toru
    Tamura, Gen
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : 612 - 618
  • [39] Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact
    Sterlacci, William
    Savic, Spasenija
    Schmid, Thomas
    Oberaigner, Wilhelm
    Auberger, Jutta
    Fiegl, Michael
    Tzankov, Alexandar
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 946 - 956
  • [40] Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?
    Riely, Gregory J.
    Travis, William D.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) : 1240 - 1242